TVJ-23095-28840
3 vaccinations
3 coded responses
26 check-ins
3 free-text entries
1 call case
- Sex
- —
- Age at first dose
- 31-35
- ZIP prefix
- 028 / RI
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Dose 1 — Pfizer-BioNTech
-
2021-01-11
Registered in v-safe
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-01-12
- 2021-01-13
- 2021-01-16
- 2021-01-21
-
2021-01-28
Dose 2 — Pfizer-BioNTech
- 2021-01-28
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-01
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-02-06
- 2021-02-11
- 2021-02-18
-
2021-02-25
Survey response — day 28, dose 2MedDRA: Abdominal discomfort, Gastrointestinal disorder, Headache — Feeling: PoorFree text: Headache stomach issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
- 2021-03-11
- 2021-04-29
-
2021-07-29
Survey response — 6 months, dose 2MedDRA: Cystitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: CystitisMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-29
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-10
- 2021-08-13
-
2022-01-30
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-03-21
Dose 3 — Pfizer-BioNTech
- 2022-04-21
- 2022-04-25
- 2022-05-02
- 2022-06-20
- 2022-09-21
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech | |
| 3 | 2022-03-21 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-29 | Unsuccessful |
Free text
Release 4 — day 28, dose 2
Symptoms: Headache stomach issues
Release 9 — 6 months, dose 2
Symptoms: Cystitis
Release 11 — 12 months, dose 2
Symptoms: COVID Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | ✓ | ○ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Cystitis | ✓ | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release